Literature DB >> 27050218

A 21-Gene Expression Assay in Breast Cancer.

Theodoros Foukakis1, Claudette Falato1, Jonas Bergh1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27050218     DOI： 10.1056/NEJMc1515988

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  3 in total

1.  A response prediction model for taxane, cisplatin, and 5-fluorouracil chemotherapy in hypopharyngeal carcinoma.

Authors:  Qi Zhong; Jugao Fang; Zhigang Huang; Yifan Yang; Meng Lian; Honggang Liu; Yixiang Zhang; Junhui Ye; Xinjie Hui; Yejun Wang; Ying Ying; Qing Zhang; Yingduan Cheng
Journal:  Sci Rep       Date:  2018-08-23       Impact factor: 4.379

Review 2.  Avoiding over- and undertreatment in patients with resected node-positive breast cancer with the use of gene expression signatures: are we there yet?

Authors:  A Matikas; T Foukakis; S Swain; J Bergh
Journal:  Ann Oncol       Date:  2019-07-01       Impact factor: 32.976

3.  The impact of Oncotype DX testing on adjuvant chemotherapy decision making in 1-3 node positive breast cancer.

Authors:  Yogeshkumar Malam; Mohamed Rabie; Konstantinos Geropantas; Susanna Alexander; Simon Pain; Mina Youssef
Journal:  Cancer Rep (Hoboken)       Date:  2021-10-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.